Organisation paid for research Program year 2022 Source: CMS Open Payments

Midwest Cardiovascular

Neither a doctor nor a teaching hospital

Research payments

$107,932

13 payments

Through program year 2022, Midwest Cardiovascular is reported as receiving $107,932 in research payments, across 13 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$21,023	1
2021	Research	$2,500	1
2020	Research	$42,503	5
2019	Research	$41,906	6

Breakdown

Who paid Research payments · program years 2019–2022

Bard Peripheral Vascular, Inc. $63,913 5 payments
AstraZeneca Pharmaceuticals LP $27,240 5 payments
AstraZeneca UK Limited $16,106 2 payments
E.R. Squibb & Sons, L.L.C. $672 1 payment

Studies the money was for Research payments · program years 2019–2022

A Long Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia $22,910 6 payments
Vernacular Bpv14007 $21,740 3 payments
DCB Iss $21,150 1 payment
Rotarex Study $21,023 1 payment
A Multinational Randomised Double Blind Placebo Controlled Trial to Evaluate the Effect of Ticagrelor 90 mg twice daily on the Incidence of Cardiovascular Death Myocardial Infarction or Stroke in Patients with Type 2 Diabetes $20,437 1 payment
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Int $672 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.